Tech Company Financing Transactions
Attivare Therapeutics Funding Round
Attivare Therapeutics, based in Natick, secured $6.6 million in investment from Bill & Melinda Gates Foundation.
Transaction Overview
Company Name
Announced On
12/15/2025
Transaction Type
Debt
Amount
$6,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
22 Stratmore Rd 241
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Undisclosed
Website
Email Address
Overview
Attivare Therapeutics, founded by a dedicated team from the Wyss Institute at Harvard, is focused on tackling the formidable challenge of treating tumors with low immunogenicity. Our innovative approach centers around the development of the ATTimmune platform. This groundbreaking technology utilizes our proprietary biomaterial scaffold, capable of recruiting, reprogramming, and releasing target immune cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Sherris
Browse more venture capital transactions:
Prev: 12/15/2025: Bloxley venture capital transaction
Next: 12/15/2025: Random Power venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs